On World Hepatitis Day, the Prevent Cancer Foundation is partnering with Hep B Free San Francisco and the San Francisco Hepatitis C Task Force to bring its Think About the Link™ campaign to San Francisco with the goal of increasing awareness of the connection between the hepatitis B and C viruses and liver cancer. San Francisco’s rate of newly reported chronic hepatitis C cases is twice California’s statewide rate, which is the highest in the U.S. San Francisco also has the highest rate of newly reported chronic hepatitis B cases among populous local health jurisdictions in California.
San Francisco’s diverse community is particularly at risk for the liver cancer-causing hepatitis B and C viruses. In fact, sixty-six percent of chronic hepatitis B cases in California occur in Asian-American and Pacific-Islanders, who make up 33 percent of San Francisco’s population. There is a vaccine to protect against hepatitis B and screenings and treatments to diagnose and cure hepatitis C. Yet, too many San Franciscans are unaware of or cannot access these cancer-preventing strategies.
On July 28, the Foundation, Hep B Free San Francisco and the San Francisco Hepatitis C Task Force will convene local health care leaders, policy influencers, advocates and members of the media for a press briefing focused on the link between hepatitis B and C viruses and liver cancer. Experts will discuss strategies to address high rates of both viruses in the community, including how to improve awareness of and access to vaccines, screenings and treatments in San Francisco to prevent the viruses, and ultimately, cancer. In addition, free hepatitis B and C screenings will be offered at the Adult Immunization Travel Clinic at 101 Grove Street, Room 102 from 10:30-11:30 A.M.
On World Hepatitis Day, the Prevent Cancer Foundation is partnering with Hep B Free San Francisco and the San Francisco Hepatitis C Task Force to bring its Think About the Link™ campaign to San Francisco with the goal of increasing awareness of the connection between the hepatitis B and C viruses and liver cancer. San Francisco’s rate of newly reported chronic hepatitis C cases is twice California’s statewide rate, which is the highest in the U.S. San Francisco also has the highest rate of newly reported chronic hepatitis B cases among populous local health jurisdictions in California.
San Francisco’s diverse community is particularly at risk for the liver cancer-causing hepatitis B and C viruses. In fact, sixty-six percent of chronic hepatitis B cases in California occur in Asian-American and Pacific-Islanders, who make up 33 percent of San Francisco’s population. There is a vaccine to protect against hepatitis B and screenings and treatments to diagnose and cure hepatitis C. Yet, too many San Franciscans are unaware of or cannot access these cancer-preventing strategies.
On July 28, the Foundation, Hep B Free San Francisco and the San Francisco Hepatitis C Task Force will convene local health care leaders, policy influencers, advocates and members of the media for a press briefing focused on the link between hepatitis B and C viruses and liver cancer. Experts will discuss strategies to address high rates of both viruses in the community, including how to improve awareness of and access to vaccines, screenings and treatments in San Francisco to prevent the viruses, and ultimately, cancer. In addition, free hepatitis B and C screenings will be offered at the Adult Immunization Travel Clinic at 101 Grove Street, Room 102 from 10:30-11:30 A.M.
read more
show less